Malaria vaccine trial shows the potentiating power of incremental progress

Brandon Wilder

doi:10.1016/j.medj.2021.05.004

Malaria vaccine trial shows the potentiating power of incremental progress

Med. 2021 Jun 11;2(6):635-636. doi: 10.1016/j.medj.2021.05.004. Epub 2021 Jun 15.

Author

Brandon Wilder¹

Affiliation

¹ Vaccine and Gene Therapy Institute, Oregon Health and Sciences University, Beaverton, OR, USA. Electronic address: wilderb@ohsu.edu.

PMID: 35590135
DOI: 10.1016/j.medj.2021.05.004

Abstract

The complexity of malaria has precluded many "slam dunk" attempts at a vaccine. In this issue, Minassian et al.¹ present efficacy trial results that demonstrate progress for a much-anticipated malaria vaccine candidate and pave the way to future iterations by validating a comprehensive vaccine development framework.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Clinical Trials as Topic
Humans
Malaria Vaccines* / therapeutic use
Malaria* / prevention & control
Malaria, Falciparum*

Substances

Malaria Vaccines

Grants and funding

R01 AI123182/AI/NIAID NIH HHS/United States